disease-drug-intelligence

Name: disease-drug-intelligence
Availability: InStock
Author: PharMolix

Consolidate multi-database evidence to identify innovative drug opportunities for a specified disease.

1.1k|132|Updated Apr 13, 2023

Search Tags:#disease #chembl #pharmacology #clinical-trials #multidatabase #innovative-drug #evidence-integration

Ready to run

npx skills add https://github.com/PharMolix/OpenBioMed --skill disease-drug-intelligence

💬 Prompt for ChatGPT / Claude Chat▼

Please help me install this Agent Skill.
Skill: disease-drug-intelligence
Source: https://github.com/PharMolix/OpenBioMed/tree/main/skills/disease-drug-intelligence
Command: npx skills add https://github.com/PharMolix/OpenBioMed --skill disease-drug-intelligence

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill includes references (resource) components.

What problem does it solve?

本技能将疾病相关的创新药情报从本地数据库与工具中整合，提供结构化、可追溯的证据报告，帮助研究者和决策者快速获取证据链完整的洞见。

Core Features & Use Cases

标准化疾病实体并识别关键靶点与机制方向。
通过本地 ChEMBL、ClinicalTrials 与 Search 等工具聚合药物候选、证据与临床进展，执行去重与证据整合。
依据固定模板输出中文综合分析报告，便于团队对比与决策。

Quick Start

Generate an integrated disease-to-innovative-drug report for a specified disease.

Frequently Asked Questions about disease-drug-intelligence

High-intent search queries and answers about installing and using this skill.

FAQPage Schema

How do I consolidate multi-database evidence to identify innovative drug opportunities for a specific disease?▼

To identify innovative drug opportunities for a disease, you need a tool that standardizes disease entities and aggregates pharmacological and clinical trial evidence. This Skill consolidates multi-database evidence into a structured report with traceable mechanisms and clinical progress validation.

What is the best way to integrate ChEMBL and ClinicalTrials data for disease-to-drug pharmacology research?▼

Integrating ChEMBL and ClinicalTrials data for pharmacology research requires standardizing disease entities and targeting mechanisms. This Skill applies local adapters to merge drug representation and clinical progress, delivering a unified report with explicit uncertainty handling.

Can I generate a structured clinical trial and drug mechanism report for disease targets?▼

Yes, you can generate a structured clinical trial and drug mechanism report for disease targets. The Skill applies standardized disease normalization and mechanism targeting to validate clinical progress, outputting a Chinese comprehensive analysis report for team decision-making.

Does this evidence integration tool support deduplication of drug candidates across multiple databases?▼

Yes, this evidence integration tool supports deduplication of drug candidates across multiple databases. It aggregates drug candidates, evidence, and clinical progress from local ChEMBL, ClinicalTrials, and Search adapters, executing deduplication to ensure a consolidated and traceable final report.

What are the limitations of using standardized disease normalization for innovative drug discovery?▼

A limitation of using standardized disease normalization for innovative drug discovery is the inherent uncertainty in evidence integration. While the Skill consolidates multi-database evidence and targets mechanisms, it explicitly handles uncertainty and requires traceable local database adapters for accurate validation.